Moelis & Company MC
56.92 USD -1.46 (-2.50%)
At closeNov 6, 2026, 4:05 PM EST
56.92 0.00 0.00%
After hours · Nov 6, 4:05 PM ET
55.18 Day range 58.06
51.38 52-week range 77.75
- YTD
- -17.20%
- 1 year
- -9.55%
- Market cap
- 4.22B
- Revenue (ttm)
- 1.64B
- Profit margin
- 14.22%
- EPS (ttm)
- 2.87
- Shares out
- 74.08M
- P/E ratio
- 19.83
- Forward P/E
- 14.66
- Dividend
- 2.60 (4.45%)
- Ex-dividend date
- Aug 9, 2026
- YTD return
- -17.20%
- 1-year return
- -9.55%
- Volume
- 1.48M
- Avg volume
- 921.57K
- Open
- 52.39
- Previous close
- 58.38
- Day's range
- 55.18 – 58.06
- 52-week range
- 51.38 – 77.75
- Analysts
- Hold
- Price target
- 67.30 (+18.2%)
- Earnings date
- Feb 3, 2027
5D -2.48 (-4.18%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 2.56
- Price / book
- 7.33
- Dividend yield
- 4.45%
- Payout ratio
- 90.59%
- Revenue growth
- 19.20%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 7.72%
- 50-day average
- 59.60
- 200-day average
- 63.65
Analyst view
Consensus: hold
Hold
Price target (mean) 67.30 +18.2% upside
Now 56.92
- Target (low)
- 58.00
- Target (mean)
- 67.30
- Target (high)
- 80.00
Ratings (0m) 11 4 buy · 6 hold · 1 sell
- Strong buy2
- Buy2
- Hold6
- Sell1
- Strong sell0
Next earnings
Feb 3, 2027
Expected Feb 3, 2027. Consensus EPS estimate 1.19.
Financials — quick view
MC Revenue — quarterly 409.39M
MC Net income — quarterly 48.59M
MC EPS — quarterly 0.64
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 3, 2027 | Dec 30, 2026 | 1.20 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 0.724 | 0.75 | +0.03 | +3.59% |
| Jul 29, 2026 | Jun 30, 2026 | 0.617 | 0.63 | +0.01 | +2.11% |
| Apr 29, 2026 | Mar 31, 2026 | 0.59 | 0.50 | -0.09 | -15.25% |
| Feb 4, 2026 | Dec 31, 2025 | 0.76 | 1.13 | +0.37 | +48.68% |
| Oct 29, 2025 | Sep 30, 2025 | 0.57 | 0.68 | +0.11 | +19.30% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 8, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Oct 7, 2026 | UBS | up | Sell | Neutral |
| Oct 1, 2026 | Goldman Sachs | main | Neutral | Neutral |
| Jul 30, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Jul 10, 2026 | Keefe, Bruyette & Woods | main | Market Perform | Market Perform |
About Moelis & Company
Moelis & Company operates as an investment banking advisory company in North and South America, Europe, the Middle East, Asia, and Australia. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic advisory, capital markets, capital structure advisory, and private capital advisory. The company serves public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds clients. Moelis & Company was founded in 2007 and is headquartered in New York, New York.
- Sector
- Financial Services
- Industry
- Capital Markets
- Country
- United States
- Website
- moelis.com
News
What Moelis & Company (MC) Said on Its Q3 Earnings Call 
Moelis & Company (MC) Q3 2026 Earnings Call Transcript 
Moelis Q3 2026 Earnings Call Transcript 
CORRECTION: Moelis Q3 Adj. EPS $0.74 Beats $0.72 Estimate, Sales $425.577M Miss $437.106M Estimate 
JP Morgan Maintains Neutral on Moelis, Lowers Price Target to $68 
Morgan Stanley Maintains Overweight on Moelis, Lowers Price Target to $77 
UBS Upgrades Moelis to Neutral, Lowers Price Target to $59 
Goldman Sachs Maintains Neutral on Moelis, Lowers Price Target to $62 
Morgan Stanley Maintains Overweight on Moelis, Raises Price Target to $85 - Moelis Q2 Adj. EPS $0.63 Beats $0.62 Estimate, Sales $409.387M Beat $385.477M Estimate
Your note
Sign in to keep a note on MC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLISON JOHN A IV | Director | Stock Award(Grant) | Dec 1, 2024 | 5,263 |
| CALLESANO CHRISTOPHER | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 18, 2026 | 2,292 |
| CANTOR ERIC | Officer and Director | Conversion of Exercise of derivative security | Feb 18, 2026 | 236,948 |
| MAHMOODZADEGAN NAVID | President | Sale | Feb 18, 2025 | 197,602 |
| MOELIS KENNETH D | Officer and Director | Conversion of Exercise of derivative security | Oct 29, 2026 | 209,318 |
| PILCHER CIAFONE KATHERINE | Chief Operating Officer | Conversion of Exercise of derivative security | Feb 18, 2026 | 7,969 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.23% | 9,057,944 | 513.70M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 7.31% | 5,412,938 | 306.98M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.06% | 4,487,258 | 254.49M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.52% | 3,351,361 | 190.07M | Jun 29, 2026 |
| State Street Corporation | 4.11% | 3,044,858 | 172.68M | Jun 29, 2026 |
| Charles Schwab Investment Management, Inc. | 3.99% | 2,955,235 | 167.60M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.11% | 3,787,297 | 214.79M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 2,363,831 | 134.06M | Jun 29, 2026 |
| SCHWAB STRATEGIC TRUST-Schwab US Dividend Equity ETF | 2.74% | 2,031,473 | 115.21M | Aug 30, 2026 |
| Touchstone Fd.s Group TRT-Touchstone Fd.s Group TRT-Touchstone Mid Cap | 2.64% | 1,954,321 | 110.84M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.30% | 1,706,260 | 96.77M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.99% | 1,470,957 | 83.42M | Sep 29, 2026 |